Loading...
BSEM logo

BioStem Technologies Community

OTCPK:BSEM Community
  • 1 Narratives written by author
  • 1 Comments on narratives written by author
  • 41 Fair Values set on narratives written by author

Community Investing Ideas

BSEM logo
BioStem Technologies

VENDAJE AC National Launch And BioRetain Data To Drive Future Market Expansion

Key Takeaways Strategic collaborations and successful CMS partnerships can enhance market adoption and pricing stability, boosting net margins and profitability. Expanding clinical trials and NASDAQ uplisting may increase revenue, earnings, and shareholder value through broader market access and investor reach.Read more

View narrative
0users have liked this narrative
1users have commented on this narrative
17users have followed this narrative
US$49.56
90.2% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
27.09% p.a.
Profit Margin
11.67%
Future PE
13.13x
Share price in 2028
US$37.76